This contract opportunity is for suppliers of pharmaceutical specialties in France. The buyer, PHARMSERA, is seeking proposals for the supply of specialized pharmaceutical products for the years 2026 to 2028. The total value of the contract is approximately €305 million. Interested suppliers should
Contract awarded. Originally published 11 months ago.
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
